VPAC2 Inhibitors

VPAC2 inhibitors encompass a diverse range of chemicals that indirectly modulate the activity of VPAC2 through the manipulation of the cyclic AMP (cAMP) pathway. Given that VPAC2's primary function relates to its role in cAMP signaling, the focus of these inhibitors is on altering the production, degradation, or response to cAMP, thereby affecting VPAC2 signaling indirectly. This is achieved through various mechanisms, such as influencing adenylate cyclase, which synthesizes cAMP, or targeting phosphodiesterases that degrade cAMP.

The chemical class of VPAC2 inhibitors includes agents like prostaglandin E2, which decreases cAMP levels, thus potentially reducing VPAC2 signaling. Conversely, chemicals like Forskolin and IBMX, known to increase cAMP production or prevent its degradation, can also modulate VPAC2 activity, albeit in a different manner. Protein kinase A inhibitors such as H-89 and KT 5720 also play a role in this class, as they affect the downstream signaling cascades initiated by cAMP, which are crucial for VPAC2's function.